Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights

NEXT STORY
Eton Pharmaceuticals Reports Second Quarter Financial Results
PREV STORY
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

electroCore Provides Business Update and Select Financial Guidance

author_avatar
NASDAQ Market News

Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC)

author_avatar
NASDAQ Market News